PhD Student

Education:

2021 : 1-year degree – Data Protection Officer, Paris Panthéon-Assas University

October 2018 – onwards: PhD Student in Public Health (ISPED) 

Research title : Survival endpoints to assess treatment outcomes in patients with metastatic breast cancer: Contribution of real world data  (Directors: Carine Bellera and Sophie Gourgou)

2017  : Master of Science, Public Health, Epidemiology, Paris Sud University

2011: 1-year degree in Statistics and Life Science, Clinical Epidemiology, Paris Sud University

 

 

 

 

Current position:

2017 – 2021: Clinical Informatics Manager, UNICANCER, Data Office

 

Publications:

Oncology-related publications:

Bringuier, Michael, Matthieu Carton, christelle Levy, Anne Patsouris, David Pasquier, Marc Debled, Olivier Rigal, et al. ‘Enrollment of Older Metastatic Breast Cancer Patients in First Line Clinical Trials: 9-Year Experience of the Large-Scale Real-Life Multicenter French ESME Cohort’. Preprint. In Review, 22 June 2021.

Annonay M, Gauquelin L, Geiss R, Ung M, Cristol-Dalstein L, Mouret-Reynier M-A, et al. Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database. The Breast. 2021 Dec;60:138–46.

Grinda T, Joyon N, Lusque A, Lefèvre S, Arnould L, Penault-Llorca F, et al. Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort. npj Breast Cancer. 2021 Dec;7(1):41.

Corbaux, Pauline, Audrey Lardy-Cleaud, Marie Alexandre, Maxime Fontanilles, Christelle Lévy, Alessandro Adriano Viansone, Audrey Mailliez, et al. ‘Progression-Free Survival on Endocrine Therapy, before or after Chemotherapy, in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer’. Breast Cancer Research and Treatment, 23 October 2021.

Grinda T, Antoine A, Jacot W, Blaye C, Cottu P-H, Diéras V, et al. Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort. ESMO Open. 2021 Apr 22;6(3):100114.

Carausu M, Carton M, Darlix A, Pasquier D, Leheurteur M, Debled M, et al. Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database. ESMO Open. 2021 May 10;6(3):100150.

Sirieix J, Fraisse J, Mathoulin-Pelissier S, Leheurteur M, Vanlemmens L, Jouannaud C, Diéras, et al. Management and Outcome of Male Metastatic Breast Cancer in the National Multicenter Observational Research Program Epidemiological Strategy and Medical Economics (ESME). Therapeutic Advances in Medical Oncology 12 (2020): 1758835920980548.

Saleh K, Carton M, Dieras V, Heudel P-E, Brain E, D’Hondt V, et al. Impact of body mass index on overall survival in patients with metastatic breast cancer. Breast. 2020 Dec 1;55:16–24.

Frasca M, Sabathe C, Delaloge S, Galvin A, Patsouris A, Levy C, et al. Palliative care delivery according to age in 12,000 women with metastatic breast cancer: Analysis in the multicentre ESME-MBC cohort 2008–2016. European Journal of Cancer. 2020 Sep 1;137:240–9.

Pons-Tostivint E, Kirova Y, Lusque A, Campone M, Geffrelot J, Rivera S, et al. Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis. Radiotherapy and Oncology. 2020 Apr;145:109–16.

Deluche E, Antoine A, Bachelot T, Lardy-Cleaud A, Dieras V, Brain E, et al. Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016. Eur J Cancer. 2020 Apr;129:60–70.

Pasquier D, Darlix A, Louvel G, Fraisse J, Jacot W, Brain E, et al. Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort. European Journal of Cancer. 2020 Jan;125:22–30.

Jacot W, Heudel P, Fraisse J, Gourgou S, Guiu S, Dalenc F, et al. Real‐life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program. Int J Cancer. 2019 Dec 15;145(12):3359–69.

Le Saux O, Lardy-Cleaud A, Frank S, Debled M, Cottu PH, Pistilli B, et al. Assessment of the efficacy of successive endocrine therapies in hormone receptor–positive and HER2-negative metastatic breast cancer: a real-life multicentre national study. European Journal of Cancer. 2019 Sep;118:131–41.

Gobbini E, Ezzalfani M, Dieras V, Bachelot T, Brain E, Debled M, et al. Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort. European Journal of Cancer. 2018 Jun;96:17–24.

Courtinard C, Robain M, Bousquet P-J, Pérol D, Cossais S, Vanni A, et al. Construction de paramètres d’extrapolation des résultats statistiques de la cohorte ESME Sein métastatique – Reconstruction d’une cohorte de patients traités pour un cancer du sein métastatique dans un CLCC à partir de la cohorte Cancer de l’INCa. Rev DÉpidémiologie Santé Publique. 2018 May;66:S184–5.

Fraisse J, Jacot W, Lardy-Cleaud A, Lusque A, Saint-Martin C, Chabaud S, et al. Utilisation du score de propension : application aux données ESME, pour évaluer l’activité de l’Eribuline en pratique réelle chez les patients atteints d’un cancer du sein métastatique. Rev DÉpidémiologie Santé Publique. mai 2018;66:S144.

Ezzalfani M, Delaloge S, Porcher R, Savignoni A, Courtinard C, Chenuc G, et al. Addressing the issue of bias in observational studies : Instrumental variable & Quasi-trial in ESME Research program. Rev DÉpidémiologie Santé Publique. mai 2018;66:S141‑2.

Courtinard C, Asselain B, Brain E, Piot I, Payen O, Campion L, et al. Construction et évaluation d’un substitut de l’indice fonctionnel ECOG (PS), mesure de l’état de santé général du patient au diagnostic du cancer du sein métastatique. Rev DÉpidémiologie Santé Publique. 2018 May;66:S177–8.

Delaloge S, Pérol D, Courtinard C, Brain E, Asselain B, Bachelot T, et al. Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study. Ann Oncol Off J Eur Soc Med Oncol. 2016 Sep;27(9):1725–32.

Guesmia T, Courtinard C, Bachelot F, Mons M, Jaffre A, Guizrad AV, et al. Données de vraie vie en oncologie. Méthodologie de constitution d’une plateforme de données exhaustives multisources : l’exemple de la base ESME. Rev DÉpidémiologie Santé Publique. 2017 May;65:S49.

Guesmia T, Robain M, Perol D, Favier B, Berchery D, Cauchois D, et al. Plateforme de données de vie réelle ESME. Constitution d’une liste de sélection exhaustive multi-source. Rev DÉpidémiologie Santé Publique. 2016 May;64:S119–20.

Other publications:

Babineaux S, Miller L, Courtinard C, Toaima D, Tahbaz A, Zagar A, et al. An Epidemiological Study of the Lifestyle and Treatment Changes in Patients With Diabetes Before Initiation of Ramadan Fasting Period. International Diabetes Federation (IDF) 21st World Diabetes Congress; December 4–8, 2011; Dubai, UAE.

Babineaux, C. Courtinard, D. Toaima, A. Tahbaz, A. Zagar, K. Boye. Use of Treatment Guidelines and Changes to Drug Regimens to Manage Patients with Type 1 and Type 2 Diabetes Fasting During Ramadan. International Diabetes Federation (IDF) 21st World Diabetes Congress; December 4–8, 2011; Dubai, UAE.

Barhdadi R, Courtinard C, Nédélec JY, Troupel M. Room-temperature ionic liquids as new solvents for organic electrosynthesis. The first examples of direct or nickel-catalysed electroreductive coupling involving organic halides. Chem Commun Camb Engl. 2003 Jun 21;(12):1434–5.

 

Département de recherche santé publique Université de Bordeaux logo_ISPED logo_INRIA logo_HONcode